The losartan renal protection study - rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) (2000)

Author(s): Brenner BM, Cooper ME, de Zeeuw D, Grunfeld J-P, Kean WF, Kurokawa K, McGill JB, Mitch WE, Parving HH, Ribeiro AB, Schluchter MD, Snavely D, Zhang Z, Simpson R, Ramjit D, Shahnaz S, Weaver J

      • Date: 01-12-2000
      • Journal: Journal of the Renin-Angiotensin-Aldosterone System
      • Volume: 1
      • Issue: 4
      • Pages: 328- 335
      • Publisher: Sage Publications
      • Publication type: Article
      • Bibliographic status: Published

      Dr Jolanta Weaver
      Senior Lecturer